PL3638673T3 - Tetrahydropirydopirazynowe modulatory GPR6 - Google Patents

Tetrahydropirydopirazynowe modulatory GPR6

Info

Publication number
PL3638673T3
PL3638673T3 PL18818829.6T PL18818829T PL3638673T3 PL 3638673 T3 PL3638673 T3 PL 3638673T3 PL 18818829 T PL18818829 T PL 18818829T PL 3638673 T3 PL3638673 T3 PL 3638673T3
Authority
PL
Poland
Prior art keywords
tetrahydropyridopyrazine
gpr6
modulators
tetrahydropyridopyrazine modulators
Prior art date
Application number
PL18818829.6T
Other languages
English (en)
Inventor
Jason W. Brown
Stephen Hitchcock
Maria HOPKINS
Shota Kikuchi
Holger Monenschein
Holly REICHARD
Kristin SCHLEICHER
Huikai SUN
Todd MACKLIN
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL3638673T3 publication Critical patent/PL3638673T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18818829.6T 2017-06-15 2018-06-15 Tetrahydropirydopirazynowe modulatory GPR6 PL3638673T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762520430P 2017-06-15 2017-06-15
US201762591247P 2017-11-28 2017-11-28
US201862649856P 2018-03-29 2018-03-29
US201862672261P 2018-05-16 2018-05-16
PCT/US2018/037687 WO2018232202A1 (en) 2017-06-15 2018-06-15 Tetrahydropyridopyrazine modulators of gpr6

Publications (1)

Publication Number Publication Date
PL3638673T3 true PL3638673T3 (pl) 2024-11-18

Family

ID=64656005

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18818829.6T PL3638673T3 (pl) 2017-06-15 2018-06-15 Tetrahydropirydopirazynowe modulatory GPR6

Country Status (25)

Country Link
US (1) US10406157B2 (pl)
EP (1) EP3638673B9 (pl)
JP (2) JP7460369B2 (pl)
KR (1) KR102802861B1 (pl)
CN (1) CN110730781B (pl)
AU (1) AU2018285677B2 (pl)
CA (1) CA3067032A1 (pl)
CO (1) CO2019015086A2 (pl)
DK (1) DK3638673T3 (pl)
ES (1) ES2988680T3 (pl)
FI (1) FI3638673T3 (pl)
HR (1) HRP20241231T1 (pl)
HU (1) HUE068346T2 (pl)
IL (1) IL271332B2 (pl)
JO (1) JOP20180057A1 (pl)
LT (1) LT3638673T (pl)
MX (1) MX2019014940A (pl)
PH (1) PH12019502792A1 (pl)
PL (1) PL3638673T3 (pl)
PT (1) PT3638673T (pl)
RS (1) RS66018B1 (pl)
SG (1) SG11201912149WA (pl)
SI (1) SI3638673T1 (pl)
TW (1) TWI775874B (pl)
WO (1) WO2018232202A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US7229557B2 (en) * 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
US20120101106A1 (en) * 2009-07-09 2012-04-26 Mercer Swati P Tetrahydronapthyridine Orexin Receptor Antagonists
JO3466B1 (ar) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
EP3105216B1 (en) * 2014-02-14 2018-10-10 Takeda Pharmaceutical Company Limited Pyrazine modulators of gpr6
JP6526034B2 (ja) * 2014-02-14 2019-06-05 武田薬品工業株式会社 Gpr6のピリドピラジンモジュレーター

Also Published As

Publication number Publication date
BR112019026430A2 (pt) 2020-07-14
NZ759708A (en) 2024-04-26
IL271332B (en) 2022-10-01
JOP20180057A1 (ar) 2019-01-30
RS66018B1 (sr) 2024-11-29
AU2018285677B2 (en) 2022-07-14
RU2019144408A (ru) 2021-07-15
HRP20241231T1 (hr) 2024-12-20
TWI775874B (zh) 2022-09-01
CN110730781A (zh) 2020-01-24
DK3638673T3 (da) 2024-09-16
LT3638673T (lt) 2024-09-10
TW201906844A (zh) 2019-02-16
AU2018285677A1 (en) 2019-12-19
EP3638673B9 (en) 2024-11-20
RU2019144408A3 (pl) 2021-09-07
US10406157B2 (en) 2019-09-10
IL271332B2 (en) 2023-02-01
IL271332A (en) 2020-01-30
WO2018232202A1 (en) 2018-12-20
EP3638673A1 (en) 2020-04-22
SG11201912149WA (en) 2020-01-30
EP3638673B1 (en) 2024-07-17
PT3638673T (pt) 2024-10-07
US20180360831A1 (en) 2018-12-20
JP7497400B2 (ja) 2024-06-10
MX2019014940A (es) 2020-02-19
JP2020523287A (ja) 2020-08-06
EP3638673A4 (en) 2021-03-24
JP2022188199A (ja) 2022-12-20
JP7460369B2 (ja) 2024-04-02
FI3638673T3 (fi) 2024-09-13
SI3638673T1 (sl) 2025-01-31
KR20200014796A (ko) 2020-02-11
KR102802861B1 (ko) 2025-04-30
CO2019015086A2 (es) 2020-04-13
ES2988680T3 (es) 2024-11-21
CN110730781B (zh) 2023-05-05
HUE068346T2 (hu) 2024-12-28
PH12019502792A1 (en) 2020-09-14
CA3067032A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
SI3743406T1 (sl) Modulatorji TMEM16A
DK3331876T3 (da) Modulators of ror-gamma
IL283967A (en) Modulators of hsd17b13 expression
IL281492A (en) Modulators of pnpla3 expression
EP3691664A4 (en) HANDLING OF TRYPTAMINE METABOLISM
IL268731A (en) New uses of anti-sirpg antibodies
EP3728260A4 (en) SPIRO EXO-AZA INHIBITORS OF MENIN-MLL INTERACTION
IL272851A (en) Methods of using dipivefrin
GB201700711D0 (en) Application of an optical effect
EP3721889A4 (en) Use of butyribacter intestini
EP3548620A4 (en) MODULATION OF THE EXPRESSION OF LNC05
IL271359A (en) Modulators of alpha-synuclein
PL3638673T3 (pl) Tetrahydropirydopirazynowe modulatory GPR6
UA36785S (uk) Комплект етикеток
UA36777S (uk) Комплект етикеток
UA36511S (uk) Комплект етикеток
UA36757S (uk) Комплект етикеток
UA36378S (uk) Комплект етикеток
UA36367S (uk) Комплект етикеток
UA36364S (uk) Комплект етикеток
UA36348S (uk) Комплект етикеток
UA36405S (uk) Комплект етикеток
IT201700010606A1 (it) GenialCombi di Moscarelli
UA36329S (uk) Комплект етикеток
UA36324S (uk) Комплект етикеток